These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 12510953

  • 1. From adrenaline to formoterol: advances in beta-agonist therapy in the treatment of asthma.
    Campbell LM.
    Int J Clin Pract; 2002 Dec; 56(10):783-90. PubMed ID: 12510953
    [Abstract] [Full Text] [Related]

  • 2. State of the art in beta2-agonist therapy: a safety review of long-acting agents.
    Rabe KF.
    Int J Clin Pract; 2003 Oct; 57(8):689-97. PubMed ID: 14627180
    [Abstract] [Full Text] [Related]

  • 3. The use of inhaled formoterol in the treatment of asthma.
    Berger WE.
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A comparison of salmeterol and formoterol in attenuating airway responses to short-acting beta2-agonists.
    van Veen A, Weller FR, Wierenga EA, Jansen HM, Jonkers RE.
    Pulm Pharmacol Ther; 2003 Jul; 16(3):153-61. PubMed ID: 12749831
    [Abstract] [Full Text] [Related]

  • 8. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Long-acting beta-2-agonists in the treatment of asthma].
    Rochat T.
    Schweiz Med Wochenschr; 1994 Oct 01; 124(39):1714-9. PubMed ID: 7939538
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of the bronchodilating effects of inhaled formoterol, salmeterol and salbutamol in asthmatic patients.
    Grembiale RD, Pelaia G, Naty S, Vatrella A, Tranfa CM, Marsico SA.
    Pulm Pharmacol Ther; 2002 Oct 01; 15(5):463-6. PubMed ID: 12406669
    [Abstract] [Full Text] [Related]

  • 16. [symbol: see text] Seretide and [symbol: see text] Symbicort in asthma management.
    Drug Ther Bull; 2002 Aug 01; 40(8):62-4. PubMed ID: 12216339
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Combination therapy in asthma--fixed or variable dosing in different patients?
    Lötvall J.
    Curr Med Res Opin; 2004 Nov 01; 20(11):1711-27. PubMed ID: 15537472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.